318 related articles for article (PubMed ID: 22174824)
1. Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer.
Wrzeszczynski KO; Varadan V; Byrnes J; Lum E; Kamalakaran S; Levine DA; Dimitrova N; Zhang MQ; Lucito R
PLoS One; 2011; 6(12):e28503. PubMed ID: 22174824
[TBL] [Abstract][Full Text] [Related]
2. Integrative prediction of gene function and platinum-free survival from genomic and epigenetic features in ovarian cancer.
Wrzeszczynski KO; Varadan V; Kamalakaran S; Levine DA; Dimitrova N; Lucito R
Methods Mol Biol; 2013; 1049():35-51. PubMed ID: 23913207
[TBL] [Abstract][Full Text] [Related]
3. Identification of recurrent focal copy number variations and their putative targeted driver genes in ovarian cancer.
Zhang L; Yuan Y; Lu KH; Zhang L
BMC Bioinformatics; 2016 May; 17(1):222. PubMed ID: 27230211
[TBL] [Abstract][Full Text] [Related]
4. Integrative epigenomic and genomic analysis of malignant pheochromocytoma.
Sandgren J; Andersson R; Rada-Iglesias A; Enroth S; Akerstrom G; Dumanski JP; Komorowski J; Westin G; Wadelius C
Exp Mol Med; 2010 Jul; 42(7):484-502. PubMed ID: 20534969
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide identification of significant aberrations in cancer genome.
Yuan X; Yu G; Hou X; Shih IeM; Clarke R; Zhang J; Hoffman EP; Wang RR; Zhang Z; Wang Y
BMC Genomics; 2012 Jul; 13():342. PubMed ID: 22839576
[TBL] [Abstract][Full Text] [Related]
6. S-score: a scoring system for the identification and prioritization of predicted cancer genes.
de Souza JE; Fonseca AF; Valieris R; Carraro DM; Wang JY; Kolodner RD; de Souza SJ
PLoS One; 2014; 9(4):e94147. PubMed ID: 24710071
[TBL] [Abstract][Full Text] [Related]
7. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
[TBL] [Abstract][Full Text] [Related]
8. Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation.
Zheng M; Hu Y; Gou R; Nie X; Li X; Liu J; Lin B
Biomed Pharmacother; 2020 Apr; 124():109810. PubMed ID: 32000042
[TBL] [Abstract][Full Text] [Related]
9. Integrative network analysis of TCGA data for ovarian cancer.
Zhang Q; Burdette JE; Wang JP
BMC Syst Biol; 2014 Dec; 8():1338. PubMed ID: 25551281
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of cancer-associated genes in ovarian cancer.
Kwon MJ; Shin YK
Int J Mol Sci; 2011 Jan; 12(2):983-1008. PubMed ID: 21541038
[TBL] [Abstract][Full Text] [Related]
11. Integration of DNA copy number alterations and transcriptional expression analysis in human gastric cancer.
Fan B; Dachrut S; Coral H; Yuen ST; Chu KM; Law S; Zhang L; Ji J; Leung SY; Chen X
PLoS One; 2012; 7(4):e29824. PubMed ID: 22539939
[TBL] [Abstract][Full Text] [Related]
12. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
[TBL] [Abstract][Full Text] [Related]
13. Insights into Impact of DNA Copy Number Alteration and Methylation on the Proteogenomic Landscape of Human Ovarian Cancer via a Multi-omics Integrative Analysis.
Song X; Ji J; Gleason KJ; Yang F; Martignetti JA; Chen LS; Wang P
Mol Cell Proteomics; 2019 Aug; 18(8 suppl 1):S52-S65. PubMed ID: 31227599
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.
Niskakoski A; Kaur S; Staff S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
Epigenetics; 2014 Dec; 9(12):1577-87. PubMed ID: 25625843
[TBL] [Abstract][Full Text] [Related]
15. Selective gene expression profiling of mTOR-associated tumor suppressor and oncogenes in ovarian cancer.
Laudański P; Kowalczuk O; Klasa-Mazurkiewicz D; Milczek T; Rysak-Luberowicz D; Garbowicz M; Baranowski W; Charkiewicz R; Szamatowicz J; Chyczewski L
Folia Histochem Cytobiol; 2011; 49(2):317-24. PubMed ID: 21744334
[TBL] [Abstract][Full Text] [Related]
16. Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
Wang K; Lim HY; Shi S; Lee J; Deng S; Xie T; Zhu Z; Wang Y; Pocalyko D; Yang WJ; Rejto PA; Mao M; Park CK; Xu J
Hepatology; 2013 Aug; 58(2):706-17. PubMed ID: 23505090
[TBL] [Abstract][Full Text] [Related]
17. Distinct oncogenes drive different genome and epigenome alterations in human mammary epithelial cells.
Fonti C; Saumet A; Abi-Khalil A; Orsetti B; Cleroux E; Bender A; Dumas M; Schmitt E; Colinge J; Jacot W; Weber M; Sardet C; du Manoir S; Theillet C
Int J Cancer; 2019 Sep; 145(5):1299-1311. PubMed ID: 31093963
[TBL] [Abstract][Full Text] [Related]
18. Analysis in epithelial ovarian cancer identifies KANSL1 as a biomarker and target gene for immune response and HDAC inhibition.
Fejzo MS; Chen HW; Anderson L; McDermott MS; Karlan B; Konecny GE; Slamon DJ
Gynecol Oncol; 2021 Feb; 160(2):539-546. PubMed ID: 33229045
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the mitogen-activated protein kinase kinase 4 (MAP2K4) tumor suppressor gene in ovarian cancer.
Davis SJ; Choong DY; Ramakrishna M; Ryland GL; Campbell IG; Gorringe KL
BMC Cancer; 2011 May; 11():173. PubMed ID: 21575258
[TBL] [Abstract][Full Text] [Related]
20. Integrative analysis of genomic and epigenetic regulation of endometrial cancer.
Zhong Q; Fan J; Chu H; Pang M; Li J; Fan Y; Liu P; Wu C; Qiao J; Li R; Hang J
Aging (Albany NY); 2020 May; 12(10):9260-9274. PubMed ID: 32412912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
